NEW YORK (Reuters Health) – Palifermin (Kepivance) helps reduce the rate, severity, and duration of severe oral mucositis in head and neck cancer patients receiving

Pharmaceutical company CEL-SCI has begun phase III clinical trials for its immunotherapy drug Multikine in Hungary. Studies are already ongoing at 12 clinical sites in

An Illinois man who underwent surgery to remove a salivary gland tumor is suing the hospital where the procedure was done, the surgeon who performed

Patients’ lack of English literacy and their employment status do not contribute to delays in head and neck cancer diagnoses — in fact, quite the

LED Dental’s VELscope Vx will be utilized in a large-scale University of British Columbia (UBC) clinical trial designed to document the ability of tissue fluorescence

Recent advances in mass spectrometric proteomics provide a promising result in utilizing saliva to explore biomarkers for diagnostic purposes, according to researchers from the University

Health warnings on cigarette packages prompt smokers to think about quitting, according to a 14-nation study. Effective warning labels as a component of comprehensive tobacco

The Terry Fox Research Institute (TFRI) in Vancouver has launched a $4.7 million Pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral

A retrospective study in Head and Neck Oncology (May 21, 2011) provides new treatment strategies for primary tumor disease and tumor recurrence in patients with

A primary reason that head and neck cancer treatments fail is that the tumor cells become resistant to chemotherapy drugs. Now researchers at the University

Cigarette manufacturers have deceived consumers about the risks of their products for years, and remedial actions are needed so consumers can make informed decisions about

HuangshanDental.com is pleased to present a new feature series, Leaders in Dentistry, a series of interviews with researchers, practitioners, and opinion leaders who are influencing